イノベーションハブ
創薬のライフサイクルにおけるあらゆる段階の最新のブレイクスルー、技術、リソースをご紹介します。
Button Text



Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Biomarkers
Biometrics
HBS
Health Economics & Outcomes Research (HEOR)
Protein Sciences
No items found.
Pharmacology
Cell Culture & Characterization
Toxicology
Crown Bioscience

ブログ
Bridging Discovery & Clinical Translation: InoKey for Biomarker-Driven Drug Development
2月 4, 2025
スポンサー:
スポンサー
ブログを読む
Pharmacology
Protein Sciences
Inoviv
Market Access
No items found.

ブログ
Leveraging Human Pluripotent Stem Cells for Breakthroughs in Drug Discovery for Neuroscience
1月 14, 2025
ブログを読む
Pharmacology
Cell Culture & Characterization
No items found.

ブログ
Assessing the Research Value of Biospecimens for ADC Development With Ki67 Tissue Staining
1月 8, 2025
スポンサー:
スポンサー
ブログを読む
Pharmacology
BioIVT
Biomarkers
Pharmacology
HBS
Indivumed Services
Disease Models
Pharmacology
No items found.
Biomarkers
DNA & RNA
No items found.
Chemical & Compound Analysis
Björn Heitmann
Barbara Czarniecki
Bruker Corporation
No items found.
Disease Models
Jonas Treebak
Alexander Bartelt
Sable Systems International Inc.
No items found.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Michael Broder
Jesse Ortendahl
PHAR
HealthEconomics.com
Disease Models
Sue Bodine
Aurora Scientific, Inc.
American Physiological Society
Alliance for Aging Research
Disease Models
Paul Marvar
Benjamin Turley
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Market Access
Medical Communications
Health Economics & Outcomes Research (HEOR)
Steven Fountain
Sonya Snedecor
Sajjad Raza
PRECISIONheor
OPEN Health
PRMA Consulting
Scientist.com
Market Access
Medical Communications
Sajjad Raza
Steven Fountain
Sonya Snedecor
OPEN Health
PRECISIONheor
PRMA Consulting
Scientist.com
Disease Models
Stefano Gaburro
Brun Ulfhake
Tecniplast S.p.A.
American Physiological Society
Alliance for Aging Research
Disease Models
Aileen King
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Cell Culture & Characterization
Pharmacology
Toxicology
Daniel Merriman
Femi Egbebi
Krzysztof Inglot
Thermo Fisher Scientific
No items found.
Pharmacology
Jonathan Nakashima
Grace Walton
Certis Oncology Solutions, Inc.
Hera BioLabs
Scientist.com
Disease Models
Rohan Jagirdar
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Instrumentation & Products
Biometrics
Disease Models
Frazer Findlay
Alex Dimov
BIOPAC Systems Inc.
No items found.

ポッドキャスト
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
7月 13, 2026
ポッドキャストを読む
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.

































.avif)








